Thomas Patterson, MD
Infectious Disease · San Antonio, TXNPI 1730198086
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,375 of the $11,037 with a category attached, or 75.9%. Scynexis, Inc. accounts for 68.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $7,525 and has fallen 98.6% since, to $105 in 2025. Among infectious disease clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 8 payments — averaging $1379.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scynexis, Inc.$8K
- Mayne Pharma Commercial LLC$3K
- Merck$850
- Stryker$105
- Aroa Biosurgery Incorporated$21
Across 6 payments — averaging $6203.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$22K
- Mayne Pharma Commercial LLC$10K
- Scynexis, Inc.$5K
What the payments were for
- Consulting fees$8,37576%
- Speaking & faculty fees$2,00018%
- Travel & lodging$5375%
- Food & beverage$1251%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scynexis, Inc. | 1 | $7,525 |
| Mayne Pharma Commercial LLC | 2 | $2,537 |
| Merck | 3 | $850 |
| Stryker | 1 | $105 |
| Aroa Biosurgery Incorporated | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TOLSURA$2,537
- NOXAFIL$850
- ADHERUS AUTOSPRAY DURAL SEALANT$105
How this compares
$11,037 in reported general payments places this provider in the 90th percentile of 576 infectious disease providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in San Antonio
- Gregory AnsteadSan Antonio$171K
- David CheeSan Antonio$12K
- Jeffrey JonesSan Antonio$11K
- Elizabeth RaceDallas$1.5M
- Ogechika AlozieEl Paso$834K
- Joseph GatheHouston$695K
- Roy ChemalyHouston$686K
- Cedric SpakFort Worth$427K
- Ben BarnettHouston$424K
- Uriel SandkovskyDallas$320K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.